Tag: #Global Trends

Pfizer and Valneva have announced their intention to proceed with regulatory filings for their Lyme disease vaccine candidate (PF-07307405/VLA15), even... Read more

French pharmaceutical giant Sanofi entered into a strategic licensing agreement with California-based Kali Therapeutics to secure exclusive worldwide rights to... Read more

On March 23, 2026, global healthcare company Viatris Inc. announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has... Read more

On March 23, 2026, Just – Evotec Biologics announced its selection by the U.S. Biomedical Advanced Research and Development Authority... Read more

On March 23, 2026, CVC Capital Partners (CVC) announced that an investor group led by Apollo-managed funds has agreed to... Read more

On March 23, 2026, Swiss pharma giant Novartis announced plans to invest over 3.3 billion Chinese yuan (approximately $480 million)... Read more

On March 20, 2026, AstraZeneca announced its plans to establish a commercial cell therapy manufacturing base and an innovation center... Read more

On March 19, 2026, Roche Pharma India signed a Memorandum of Understanding (MoU) with the National Institute of Pharmaceutical Education... Read more

On March 19, 2026, SK pharmteco, a leading Contract Development and Manufacturing Organization (CDMO), announced a strategic $100 million funding... Read more